Greenfield Seitz Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Sell
17,202
-6,662
-28% -$464K 0.33% 61
2025
Q4
$1.58M Sell
23,864
-40,317
-63% -$2.61M 0.52% 50
2025
Q3
$4.32M Buy
64,181
+3,387
+6% +$268K 1.39% 26
2025
Q2
$5.31M Buy
60,794
+2,042
+3% +$160K 1.88% 19
2025
Q1
$4.01M Sell
58,752
-85
-0.1% -$6.94K 1.53% 27
2024
Q4
$4.58M Sell
58,837
-900
-2% -$66.6K 1.74% 23
2024
Q3
$4M Buy
59,737
+5,739
+11% +$471K 1.47% 26
2024
Q2
$6.12M Buy
53,998
+4,651
+9% +$588K 2.27% 13
2024
Q1
$6.84M Sell
49,347
-1,392
-3% -$175K 2.55% 11
2023
Q4
$6.3M Buy
+50,739
New +$5.18M 2.51% 9

Other funds holding DXCM

Greenfield Seitz Capital Management's DXCM Position: Q1 2026 in Review

Greenfield Seitz Capital Management reduced its DexCom (DXCM) stake by 28% in Q1 2026, selling an estimated $464K and leaving 17,202 shares worth $1.08M. The position accounts for 0.33% of the portfolio, ranked #61.

Greenfield Seitz Capital Management first reported a position in DXCM in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.84M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Greenfield Seitz Capital Management held 17,202 shares of DexCom worth $1.08M as of Q1 2026.
  • Greenfield Seitz Capital Management sold 6,662 DexCom shares in Q1 2026, an estimated $464K.
  • DexCom made up 0.33% of Greenfield Seitz Capital Management's portfolio in Q1 2026, its #61 holding.
  • Greenfield Seitz Capital Management first reported a position in DexCom in Q4 2023 and has held it in 10 quarters since.
  • Greenfield Seitz Capital Management's DexCom position peaked at $6.84M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Greenfield Seitz Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.